Posted On: 08/15/2016 9:05:47 AM
Post# of 94287
$ARTH News! Excellent AC5 Clinical study Results 
successfully met the objectives of its recently completed single-center, randomized, single-blind prospective clinical study (NCT 02704104) of the AC5 Topical Hemostatic Device in skin lesion patients with bleeding wounds. This was the first study assessing the safety and performance of AC5 in humans.
http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
successfully met the objectives of its recently completed single-center, randomized, single-blind prospective clinical study (NCT 02704104) of the AC5 Topical Hemostatic Device in skin lesion patients with bleeding wounds. This was the first study assessing the safety and performance of AC5 in humans. http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
(0)
(0)
